Antiaging Quantum Living Inc. Financial Summary

Quick Answer

Antiaging Quantum Living Inc. reported Total Revenue of $817.9 thousand for fiscal year 2025.

Antiaging Quantum Living Inc. — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $817.9K
+10806.8%
$7.5K
-44.9%
$13.6K
+83.8%
$7.4K
+94.7%
$3.8K
Revenue (ASC 606) $817.9K
+10806.8%
$7.5K
-44.9%
$13.6K
+83.8%
$7.4K
+94.7%
$3.8K
Net Income -$720.4K
-74.4%
-$413.0K
-1027.4%
-$36.6K
+15.7%
-$43.4K
+34.7%
-$66.5K
-12.5%
-$59.1K
+16.2%
Diluted EPS -$0.02
-73.9%
-$0.01
Total Assets $1.59M
+57.0%
$1.01M
+113145.0%
$894.00
-94.1%
$15.1K
-77.9%
$68.4K
-48.0%
$131.5K
+300.0%
Cash and Equivalents $370.5K
+122.5%
$166.6K
+46948.6%
$354.00
-97.5%
$14.3K
-18.4%
$17.5K
-71.5%
$61.5K
+1384.4%
Stockholders Equity -$1.13M
-173.5%
-$413.2K
-379.8%
-$86.1K
-74.0%
-$49.5K
-719.0%
-$6.0K
-110.0%
$60.5K
+210.4%
Operating Income -$790.0K
-91.3%
-$413.0K
-1027.5%
-$36.6K
+18.6%
-$45.0K
+38.3%
-$72.9K
-31.5%
-$55.4K
+2.9%
Gross Profit $428.5K
+6269.2%
$6.7K
-50.5%
$13.6K
+115.9%
$6.3K
+110.0%
$3.0K
Shares Outstanding 30.00M
+0.0%
30.00M
+0.0%
30.00M
+0.0%
30.00M
+0.0%
30.00M
+200.4%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue December 31, 2025 $340.3K +120.3% -12.8%
Revenue (ASC 606) December 31, 2025 $340.3K +120.3% -12.8%
Net Income December 31, 2025 -$272.2K -110.7% -341.8%
Diluted EPS December 31, 2025 -$0.01 -100.0% -309.5%
Total Assets December 31, 2025 $1.81M +14.8% -4.9%
Cash and Equivalents December 31, 2025 $936.9K +362.7% +105.7%
Stockholders Equity December 31, 2025 -$300.6K -131.8% +77.5%
Operating Income December 31, 2025 -$272.2K -36.9% -431.5%
Gross Profit December 31, 2025 $203.9K +36.6% -37.2%
Shares Outstanding December 31, 2023 30.00M +0.0% +0.0%
  • Antiaging Quantum Living Inc. reported Total Revenue of $817.9 thousand for fiscal year 2025.
  • Antiaging Quantum Living Inc. showed an increase of +10806.8% in Total Revenue compared to the prior fiscal year.
  • Antiaging Quantum Living Inc. reported Revenue (ASC 606) of $817.9 thousand for fiscal year 2025.
  • Antiaging Quantum Living Inc. showed an increase of +10806.8% in Revenue (ASC 606) compared to the prior fiscal year.
  • Antiaging Quantum Living Inc. reported Net Income of -$720.4 thousand for fiscal year 2025.
  • Antiaging Quantum Living Inc. showed a decrease of -74.4% in Net Income compared to the prior fiscal year.
  • Antiaging Quantum Living Inc. reported Diluted EPS of $0.02 per share (loss) for fiscal year 2025.
  • Antiaging Quantum Living Inc. showed a decrease of -73.9% in Diluted EPS compared to the prior fiscal year.
  • Antiaging Quantum Living Inc. reported Total Assets of $1.59 million for fiscal year 2025.
  • Antiaging Quantum Living Inc. showed an increase of +57.0% in Total Assets compared to the prior fiscal year.
  • Antiaging Quantum Living Inc. reported Cash and Equivalents of $370.5 thousand for fiscal year 2025.
  • Antiaging Quantum Living Inc. showed an increase of +122.5% in Cash and Equivalents compared to the prior fiscal year.
  • Antiaging Quantum Living Inc. reported Stockholders Equity of -$1.13 million for fiscal year 2025.
  • Antiaging Quantum Living Inc. showed a decrease of -173.5% in Stockholders Equity compared to the prior fiscal year.
  • Antiaging Quantum Living Inc. reported Operating Income of -$790.0 thousand for fiscal year 2025.
  • Antiaging Quantum Living Inc. showed a decrease of -91.3% in Operating Income compared to the prior fiscal year.
  • Antiaging Quantum Living Inc. reported Gross Profit of $428.5 thousand for fiscal year 2025.
  • Antiaging Quantum Living Inc. showed an increase of +6269.2% in Gross Profit compared to the prior fiscal year.
  • Antiaging Quantum Living Inc. reported Shares Outstanding of 30.00 million shares for fiscal year 2024.
  • Antiaging Quantum Living Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment